Multiple Sclerosis Treatment Devices Market Research Report Information by Type (Primary Progressive Multiple Sclerosis (PPMS), Secondary Progressive Multiple Sclerosis (SPMS), Relapsing-remitting Multiple Sclerosis (RRMS), Clinically Isolated Syndrome (CIS)), by Treatment Devices (Electrical Stimulation Devices (Functional Electrical Stimulation (FES), Transcutaneous Electrical Nerve Stimulation (TENS)), Neurostimulation Devices (Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS))), by End-User (Hospitals & Clinics, Ambulatory Sur

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

3.1 OVERVIEW

3.2 DATA FLOW

3.2.1 DATA MINING PROCESS

3.3 PURCHASED DATABASE:

3.4 SECONDARY SOURCES:

3.4.1 SECONDARY RESEARCH DATA FLOW:

3.5 PRIMARY RESEARCH:

3.5.1 PRIMARY RESEARCH DATA FLOW:

3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED

3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE

3.6 APPROACHES FOR MARKET SIZE ESTIMATION:

3.6.1 REVENUE ANALYSIS APPROACH

3.7 DATA FORECASTING

3.7.1 DATA FORECASTING TYPE

3.8 DATA MODELING

3.8.1 MICROECONOMIC FACTOR ANALYSIS:

3.8.2 DATA MODELING:

3.9 TEAMS AND ANALYST CONTRIBUTION

3.10 INTRODUCTION

3.11 DRIVERS

3.11.1 INCREASING PREVALENCE OF MULTIPLE SCLEROSIS (MS)

3.11.2 ADVANCEMENTS IN NEUROSTIMULATION AND WEARABLE DEVICES

3.12 RESTRAINTS

3.12.1 LIMITED AWARENESS AND ACCESSIBILITY IN DEVELOPING REGIONS

3.13 OPPORTUNITY

3.13.1 RISING COLLABORATIONS BETWEEN HEALTHCARE PROVIDERS AND TECHNOLOGY FIRMS

4 MARKET FACTOR ANALYSIS

4.1 PORTER’S FIVE FORCES MODEL

4.1.1 THREAT OF NEW ENTRANTS

4.1.2 BARGAINING POWER OF SUPPLIERS

4.1.3 THREAT OF SUBSTITUTES

4.1.4 BARGAINING POWER OF BUYERS

4.1.5 INTENSITY OF RIVALRY

4.2 IMPACT OF COVID-19 ON THE GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET

5 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE

5.1 OVERVIEW

5.2 PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS (PPMS)

5.3 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS)

5.4 RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS)

5.5 CLINICALLY ISOLATED SYNDROME (CIS)

6 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT DEVICES

6.1 INTRODUCTION

6.2 ELECTRICAL STIMULATION DEVICES

6.2.1 FUNCTIONAL ELECTRICAL STIMULATION (FES)

6.2.2 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS)

6.3 NEUROSTIMULATION DEVICES

6.3.1 SPINAL CORD STIMULATION (SCS)

6.3.2 DEEP BRAIN STIMULATION (DBS)

7 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER

7.1 OVERVIEW

7.2 HOSPITALS & CLINICS

7.3 AMBULATORY SURGICAL CENTERS

8 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET BY REGION

8.1 OVERVIEW

8.2 NORTH AMERICA

8.2.1 US

8.2.2 CANADA

8.3 EUROPE

8.3.1 GERMANY

8.3.2 FRANCE

8.3.3 UK

8.3.4 SPAIN

8.3.5 ITALY

8.3.6 RUSSIA

8.3.7 REST OF EUROPE

8.4 ASIA PACIFIC

8.4.1 CHINA

8.4.2 INDIA

8.4.3 JAPAN

8.4.4 SOUTH KOREA

8.4.5 MALAYSIA

8.4.6 THAILAND

8.4.7 INDONESIA

8.4.8 REST OF ASIA PACIFIC

8.5 SOUTH AMERICA

8.5.1 BRAZIL

8.5.2 MEXICO

8.5.3 ARGENTINA

8.5.4 REST OF SOUTH AMERICA

8.6 MIDDLE EAST AND AFRICA

8.6.1 GCC COUNTRIES

8.6.2 SOUTH AFRICA

8.6.3 REST OF MEA

9 COMPETITIVE LANDSCAPE

9.1 INTRODUCTION

9.2 MARKET SHARE ANALYSIS, 2024

9.3 COMPETITOR DASHBOARD

9.4 PUBLIC PLAYERS STOCK SUMMARY

9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL

9.1 KEY DEVELOPMENTS & GROWTH STRATEGIES

9.1.1 PRODUCT LAUNCH

9.1.2 PRODUCT APPROVAL

10 COMPANY PROFILES

10.1 ENOVIS

10.1.1 COMPANY OVERVIEW

10.1.2 FINANCIAL OVERVIEW

10.1.3 PRODUCTS OFFERED

10.1.4 KEY DEVELOPMENTS

10.1.5 SWOT ANALYSIS

10.1.6 KEY STRATEGIES

10.2 AXONICS, INC.

10.2.1 COMPANY OVERVIEW

10.2.2 FINANCIAL OVERVIEW

10.2.3 PRODUCTS OFFERED

10.2.4 KEY DEVELOPMENTS

10.2.5 KEY STRATEGIES

10.3 KONINKLIJKE PHILIPS N.V.

10.3.1 COMPANY OVERVIEW

10.3.2 FINANCIAL OVERVIEW

10.3.3 PRODUCTS OFFERED

10.3.4 KEY DEVELOPMENTS

10.3.5 SWOT ANALYSIS

10.3.6 KEY STRATEGIES

10.4 BTL

10.4.1 COMPANY OVERVIEW

10.4.2 FINANCIAL OVERVIEW

10.4.3 PRODUCTS OFFERED

10.4.4 KEY DEVELOPMENTS

10.4.5 KEY STRATEGIES

10.5 BAYER AG

10.5.1 COMPANY OVERVIEW

10.5.2 FINANCIAL OVERVIEW

10.5.3 PRODUCTS OFFERED

10.5.4 KEY DEVELOPMENTS

10.5.5 KEY STRATEGY

10.6 MEDTRONIC

10.6.1 COMPANY OVERVIEW

10.6.2 FINANCIAL OVERVIEW

10.6.3 PRODUCTS OFFERED

10.6.4 KEY DEVELOPMENTS

10.6.5 SWOT ANALYSIS

10.6.6 KEY STRATEGIES

10.7 ABBOTT

10.7.1 COMPANY OVERVIEW

10.7.2 FINANCIAL OVERVIEW

10.7.3 PRODUCTS OFFERED

10.7.4 KEY DEVELOPMENTS

10.7.5 SWOT ANALYSIS

10.7.6 KEY STRATEGIES

10.8 BOSTON SCIENTIFIC CORPORATION

10.8.1 COMPANY OVERVIEW

10.8.2 FINANCIAL OVERVIEW

10.8.3 PRODUCTS OFFERED

10.8.4 KEY DEVELOPMENTS

10.8.5 KEY STRATEGIES

10.9 BIOTRONIK

10.9.1 COMPANY OVERVIEW

10.9.2 FINANCIAL OVERVIEW

10.9.3 PRODUCTS OFFERED

10.9.4 KEY DEVELOPMENTS

10.9.5 KEY STRATEGIES

10.10 SALUDA MEDICAL PTY LTD.

10.10.1 COMPANY OVERVIEW

10.10.2 FINANCIAL OVERVIEW

10.10.3 PRODUCTS OFFERED

10.10.4 KEY DEVELOPMENTS

10.10.5 KEY STRATEGIES

11 DATA CITATIONS

11.1 DATA CITATIONS
 

LIST OF TABLES

TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT

TABLE 2 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2035 (USD BILLION)

TABLE 3 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS (PPMS), BY REGION, 2019-2035 (USD BILLION)

TABLE 4 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS), BY REGION, 2019-2035 (USD BILLION)

TABLE 5 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS), BY REGION, 2019-2035 (USD BILLION)

TABLE 6 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR CLINICALLY ISOLATED SYNDROME (CIS), BY REGION, 2019-2035 (USD BILLION)

TABLE 7 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT DEVICES, 2019-2035 (USD BILLION)

TABLE 8 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY REGION, 2019-2035 (USD BILLION)

TABLE 9 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2035 (USD BILLION)

TABLE 10 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR FUNCTIONAL ELECTRICAL STIMULATION (FES), BY REGION, 2019-2035 (USD BILLION)

TABLE 11 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS), BY REGION, 2019-2035 (USD BILLION)

TABLE 12 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY REGION, 2019-2035 (USD BILLION)

TABLE 13 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2035 (USD BILLION)

TABLE 14 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR SPINAL CORD STIMULATION (SCS), BY REGION, 2019-2035 (USD BILLION)

TABLE 15 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR DEEP BRAIN STIMULATION (DBS), BY REGION, 2019-2035 (USD BILLION)

TABLE 16 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2035 (USD BILLION)

TABLE 17 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2019-2035 (USD BILLION)

TABLE 18 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2019-2035 (USD BILLION)

TABLE 19 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY REGION, 2019-2035 (USD BILLION)

TABLE 20 NORT AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY COUNTRY, 2019-2035 (USD BILLION)

TABLE 21 NORTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2035 (USD BILLION)

TABLE 22 NORTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2035 (USD BILLION)

TABLE 23 NORTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2035 (USD BILLION)

TABLE 24 NORTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2035 (USD BILLION)

TABLE 25 NORTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2035 (USD BILLION)

TABLE 26 US MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2035 (USD BILLION)

TABLE 27 US MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2035 (USD BILLION)

TABLE 28 US MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2035 (USD BILLION)

TABLE 29 US MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2035 (USD BILLION)

TABLE 30 US MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2035 (USD BILLION)

TABLE 31 CANADA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2035 (USD BILLION)

TABLE 32 CANADA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2035 (USD BILLION)

TABLE 33 CANADA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2035 (USD BILLION)

TABLE 34 CANADA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2035 (USD BILLION)

TABLE 35 CANADA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2035 (USD BILLION)

TABLE 36 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY COUNTRY, 2019-2035 (USD BILLION)

TABLE 37 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2035 (USD BILLION)

TABLE 38 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2035 (USD BILLION)

TABLE 39 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2035 (USD BILLION)

TABLE 40 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2035 (USD BILLION)

TABLE 41 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2035 (USD BILLION)

TABLE 42 GERMANY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2035 (USD BILLION)

TABLE 43 GERMANY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2035 (USD BILLION)

TABLE 44 GERMANY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2035 (USD BILLION)

TABLE 45 GERMANY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2035 (USD BILLION)

TABLE 46 GERMANY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2035 (USD BILLION)

TABLE 47 FRANCE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2035 (USD BILLION)

TABLE 48 FRANCE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2035 (USD BILLION)

TABLE 49 FRANCE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2035 (USD BILLION)

TABLE 50 FRANCE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2035 (USD BILLION)

TABLE 51 FRANCE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2035 (USD BILLION)

TABLE 52 UK MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2035 (USD BILLION)

TABLE 53 UK MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2035 (USD BILLION)

TABLE 54 UK MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2035 (USD BILLION)

TABLE 55 UK MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2035 (USD BILLION)

TABLE 56 UK MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2035 (USD BILLION)

TABLE 57 SPAIN MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2035 (USD BILLION)

TABLE 58 SPAIN MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2035 (USD BILLION)

TABLE 59 SPAIN MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2035 (USD BILLION)

TABLE 60 SPAIN MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2035 (USD BILLION)

TABLE 61 SPAIN MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2035 (USD BILLION)

TABLE 62 ITALY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2035 (USD BILLION)

TABLE 63 ITALY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2035 (USD BILLION)

TABLE 64 ITALY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2035 (USD BILLION)

TABLE 65 ITALY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2035 (USD BILLION)

TABLE 66 ITALY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2035 (USD BILLION)

TABLE 67 RUSSIA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2035 (USD BILLION)

TABLE 68 RUSSIA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2035 (USD BILLION)

TABLE 69 RUSSIA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2035 (USD BILLION)

TABLE 70 RUSSIA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2035 (USD BILLION)

TABLE 71 RUSSIA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2035 (USD BILLION)

TABLE 72 REST OF EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2035 (USD BILLION)

TABLE 73 REST OF EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2035 (USD BILLION)

TABLE 74 REST OF EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2035 (USD BILLION)

TABLE 75 REST OF EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2035 (USD BILLION)

TABLE 76 REST OF EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2035 (USD BILLION)

TABLE 77 ASIA PACIFIC MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY REGION, 2019–2035 (USD BILLION)

TABLE 78 ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2035 (USD BILLION)

TABLE 79 ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2035 (USD BILLION)

TABLE 80 ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 81 ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 82 ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 83 CHINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2035 (USD BILLION)

TABLE 84 CHINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2035 (USD BILLION)

TABLE 85 CHINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 86 CHINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 87 CHINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 88 INDIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2035 (USD BILLION)

TABLE 89 INDIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2035 (USD BILLION)

TABLE 90 INDIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 91 INDIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 92 INDIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 93 JAPAN: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2035 (USD BILLION)

TABLE 94 JAPAN: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2035 (USD BILLION)

TABLE 95 JAPAN: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 96 JAPAN: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 97 JAPAN: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 98 SOUTH KOREA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2035 (USD BILLION)

TABLE 99 SOUTH KOREA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2035 (USD BILLION)

TABLE 100 SOUTH KOREA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 101 SOUTH KOREA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 102 SOUTH KOREA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 103 MALAYSIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2035 (USD BILLION)

TABLE 104 MALAYSIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2035 (USD BILLION)

TABLE 105 MALAYSIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 106 MALAYSIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 107 MALAYSIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 108 THAILAND: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2035 (USD BILLION)

TABLE 109 THAILAND: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2035 (USD BILLION)

TABLE 110 THAILAND: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 111 THAILAND: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 112 THAILAND: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 113 INDONESIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2035 (USD BILLION)

TABLE 114 INDONESIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2035 (USD BILLION)

TABLE 115 INDONESIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 116 INDONESIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 117 INDONESIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 118 REST OF ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2035 (USD BILLION)

TABLE 119 REST OF ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2035 (USD BILLION)

TABLE 120 REST OF ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 121 REST OF ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 122 REST OF ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 123 SOUTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY REGION, 2019–2035 (USD BILLION)

TABLE 124 SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2035 (USD BILLION)

TABLE 125 SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2035 (USD BILLION)

TABLE 126 SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 127 SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 128 SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 129 BRAZIL: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2035 (USD BILLION)

TABLE 130 BRAZIL: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2035 (USD BILLION)

TABLE 131 BRAZIL: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 132 BRAZIL: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 133 BRAZIL: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 134 MEXICO: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2035 (USD BILLION)

TABLE 135 MEXICO: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2035 (USD BILLION)

TABLE 136 MEXICO: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 137 MEXICO: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 138 MEXICO: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 139 ARGENTINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2035 (USD BILLION)

TABLE 140 ARGENTINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2035 (USD BILLION)

TABLE 141 ARGENTINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 142 ARGENTINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 143 ARGENTINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 144 REST OF SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2035 (USD BILLION)

TABLE 145 REST OF SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2035 (USD BILLION)

TABLE 146 REST OF SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 147 REST OF SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 148 REST OF SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 149 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY COUNTRY, 2019–2035 (USD BILLION)

TABLE 150 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2035 (USD BILLION)

TABLE 151 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2035 (USD BILLION)

TABLE 152 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 153 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 154 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 155 GCC COUNTRIES: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2035 (USD BILLION)

TABLE 156 GCC COUNTRIES: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2035 (USD BILLION)

TABLE 157 GCC COUNTRIES: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 158 GCC COUNTRIES: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 159 GCC COUNTRIES: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 160 SOUTH AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2035 (USD BILLION)

TABLE 161 SOUTH AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2035 (USD BILLION)

TABLE 162 SOUTH AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 163 SOUTH AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 164 SOUTH AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 165 REST OF MEA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2035 (USD BILLION)

TABLE 166 REST OF MEA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2035 (USD BILLION)

TABLE 167 REST OF MEA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 168 REST OF MEA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019–2035 (USD BILLION)

TABLE 169 REST OF MEA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 170 PRODUCT LAUNCH

TABLE 171 PRODUCT APPROVAL

TABLE 172 ENOVIS: PRODUCTS OFFERED

TABLE 173 AXONICS, INC.: PRODUCTS OFFERED

TABLE 174 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED

TABLE 175 BTL: PRODUCT OFFERED

TABLE 176 BAYER AG: PRODUCTS OFFERED

TABLE 177 MEDTRONIC: PRODUCTS OFFERED

TABLE 178 MEDTRONIC: KEY DEVELOPMENTS

TABLE 179 ABBOTT: PRODUCTS OFFERED

TABLE 180 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED

TABLE 181 ABBOTT: KEY DEVELOPMENTS

TABLE 182 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED

TABLE 183 BOSTON SCIENTIFIC CORPORATION: KEY DEVELOPMENTS

TABLE 184 SALUDA MEDICAL PTY LTD.: PRODUCTS OFFERED
LIST OF FIGURES

FIGURE 1 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET: STRUCTURE

FIGURE 2 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET: MARKET GROWTH FACTOR ANALYSIS (2024-2035)

FIGURE 3 DRIVER IMPACT ANALYSIS (2022-2035)

FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2035)

FIGURE 5 PORTER’S FIVE FORCES ANALYSIS: GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET

FIGURE 6 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET; TYPE SEGMENT ATTRACTIVENESS, (USD BILLION)

FIGURE 7 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2024 & 2035 (USD BILLION)

FIGURE 8 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET SHARE (%), BY TYPE, 2024

FIGURE 9 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET; TREATMENT DEVICES SEGMENT ATTRACTIVENESS, (USD BILLION)

FIGURE 10 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT DEVICES, 2024 & 2035 (USD BILLION)

FIGURE 11 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET SHARE (%), BY TREATMENT DEVICES, 2024

FIGURE 12 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET; END USER SEGMENT ATTRACTIVENESS, (USD BILLION)

FIGURE 13 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2024 & 2035 (USD BILLION)

FIGURE 14 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET SHARE (%), BY END USER, 2024

FIGURE 15 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY REGION, 2024 & 2035 (USD BILLION)

FIGURE 16 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET SHARE (%), BY REGION, 2024

FIGURE 17 NORTH AMERICA MARKET ANALYSIS: MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, 2019-2035 (USD BILLION)

FIGURE 18 NORTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY COUNTRY, 2024 & 2035 (USD BILLION)

FIGURE 19 NORTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET SHARE (%), BY COUNTRY, 2024

FIGURE 20 EUROPE MARKET ANALYSIS: MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, 2019-2035 (USD BILLION)

FIGURE 21 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY COUNTRY, 2024 & 2035 (USD BILLION)

FIGURE 22 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET SHARE (%), BY COUNTRY, 2024

FIGURE 23 ASIA PACIFIC MARKET ANALYSIS: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, 2019-2035 (USD BILLION)

FIGURE 24 ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD BILLION)

FIGURE 25 ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET SHARE, BY COUNTRY, 2024 (%)

FIGURE 26 SOUTH AMERICA MARKET ANALYSIS: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, 2019-2035 (USD BILLION)

FIGURE 27 SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD BILLION)

FIGURE 28 SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET SHARE, BY COUNTRY, 2024 (%)

FIGURE 29 MIDDLE EAST AND AFRICA MARKET ANALYSIS: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, 2019-2035 (USD BILLION)

FIGURE 30 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD BILLION)

FIGURE 31 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET SHARE, BY COUNTRY, 2024 (%)

FIGURE 32 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET PLAYERS: COMPETITIVE ANALYSIS, 2024

FIGURE 33 COMPETITOR DASHBOARD: GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET

FIGURE 34 ENOVIS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 35 ENOVIS: SWOT ANALYSIS

FIGURE 36 AXONICS, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 37 KONINKLIJKE PHILIPS N.V.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 38 KONINKLIJKE PHILIPS N.V.: SWOT ANALYSIS

FIGURE 39 BAYER AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 40 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 41 MEDTRONIC: SWOT ANALYSIS

FIGURE 42 ABBOTT: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 43 ABBOTT: SWOT ANALYSIS

FIGURE 44 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT